# Research-Based Product Innovation to Address Critical Unmet Needs of Patients with Inflammatory Bowel Diseases (IBD 2021)

## Unmet patient needs
1. biomarkers for prognosis of disease course and prediction/monitoring of treatment response
2. restoration of eubiosis
3. restoration of barrier function and mucosal healing
4. more effective and safer anti-inflammatories
5. neuromodulatory and behavioral therapies
6. management of disease complications
7. targeted drug delivery